Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation-Reference-Cited by-同舟云学术

Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation

Published:2022-01-11 Issue:1 Volume:35 Page:63-71
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Trontzas Ioannis P.¹^ORCID,Rapti Vasiliki E.¹,Syrigos Nikolaos K.¹,Gomatou Georgia¹,Lagou Styliani¹,Kanellis George²,Kotteas Elias A.¹

Affiliation:

1. 3rd Department of Internal Medicine, Oncology Unit, Sotiria General Hospital, Athens School of Medicine, Athens, Greece

2. Hematopathology Department, Evangelismos Hospital, Athens, Greece

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2021.2025316

Reference32 articles.

1. Capecitabine: A review

2. Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review

3. null

4. Summary of Product Characteristics- Xeloda (Capecitabine). Roche pharmaceuticals. [accessed 08 August 2020]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020896s037lbl.pdf [year of revision of the text 2015].

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capecitabine-associated gastrointestinal ulceration, haemorrhage, and obstruction: a pharmacovigilance analysis based on the FAERS;Frontiers in Pharmacology;2024-06-14

2. Capecitabine-induced severe adverse events—therapeutic drug monitoring andDPYD-gene analysis are recommended;BMJ Case Reports;2024-04

3. Recent green chemistry approaches for pyrimidine derivatives as a potential anti-cancer agent: An overview (2013–2023);Sustainable Chemistry and Pharmacy;2024-02

4. Capecitabine-induced Gastrointestinal Injury Shows a Graft-Versus-Host Disease (GVHD)-like Pattern;American Journal of Surgical Pathology;2023-07-27

5. Capecitabine-Induced Enterocolitis;Cureus;2022-03-04